Aviva plc (OTCMKTS:AVVIY - Get Free Report) was the recipient of a significant decline in short interest in the month of January. As of January 15th, there was short interest totalling 14,700 shares, a decline of 75.8% from the December 31st total of 60,800 shares. Based on an average daily trading volume, of 77,800 shares, the days-to-cover ratio is currently 0.2 days.
Analysts Set New Price Targets
Several research analysts have recently weighed in on AVVIY shares. BNP Paribas upgraded Aviva from a "strong sell" rating to a "hold" rating in a research note on Thursday, December 5th. Hsbc Global Res upgraded shares of Aviva from a "hold" rating to a "strong-buy" rating in a research report on Friday, November 15th. Royal Bank of Canada raised shares of Aviva to a "moderate buy" rating in a research report on Thursday, October 3rd. Finally, Keefe, Bruyette & Woods raised shares of Aviva from a "hold" rating to a "moderate buy" rating in a report on Wednesday, November 27th. One investment analyst has rated the stock with a hold rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Buy".
Read Our Latest Research Report on AVVIY
Aviva Stock Performance
Shares of OTCMKTS:AVVIY traded down $0.05 during midday trading on Tuesday, reaching $12.79. 30,803 shares of the company traded hands, compared to its average volume of 32,206. The firm's fifty day moving average price is $12.16 and its two-hundred day moving average price is $12.55. Aviva has a 12 month low of $10.50 and a 12 month high of $13.58.
Aviva Company Profile
(
Get Free Report)
Aviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annuity products, as well as pension fund business and lifetime mortgage products.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aviva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aviva wasn't on the list.
While Aviva currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
